2012
DOI: 10.1016/j.jmb.2012.01.029
|View full text |Cite
|
Sign up to set email alerts
|

Time-Dependent Predominance of Nonhomologous DNA End-Joining Pathways during Embryonic Development in Mice

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

2
47
0

Year Published

2013
2013
2020
2020

Publication Types

Select...
6
2

Relationship

2
6

Authors

Journals

citations
Cited by 48 publications
(49 citation statements)
references
References 67 publications
2
47
0
Order By: Relevance
“…Studies in mammalian cells have implicated DNA ligase III (Lig3) as the major alt-NHEJ ligase (Audebert et al 2004;Wang et al 2005;Sallmyr et al 2008;Simsek et al 2011;Chiruvella et al 2012). As a cofactor of Lig3, XRCC1 is also suggested to be involved (Audebert et al 2004;Saribasak et al 2011), although more recent studies suggest that XRCC1 may be dispensable (Boboila et al 2012;Han et al 2012).…”
Section: Alt-nhejmentioning
confidence: 99%
“…Studies in mammalian cells have implicated DNA ligase III (Lig3) as the major alt-NHEJ ligase (Audebert et al 2004;Wang et al 2005;Sallmyr et al 2008;Simsek et al 2011;Chiruvella et al 2012). As a cofactor of Lig3, XRCC1 is also suggested to be involved (Audebert et al 2004;Saribasak et al 2011), although more recent studies suggest that XRCC1 may be dispensable (Boboila et al 2012;Han et al 2012).…”
Section: Alt-nhejmentioning
confidence: 99%
“…CSR is no exception, and even if AID-induced DSBs in S regions would appear fairly amenable to repair by A-EJ, C-NHEJ is necessary for efficient CSR and cannot be adequately replaced by A-EJ. Recently, variations between relative C-NHEJ and A-EJ activities assessed in vitro with cell free extracts prepared from mouse embryos at different stages of development, suggested a role for A-EJ during embryogenesis [285]. However in vivo experiments are required to confirm and confidently interpret these findings.…”
Section: A-ej: the "No Pathway" Optionmentioning
confidence: 99%
“…DNA DSB's pose a serious threat to both cell viability and genome stability if left unrepaired or repaired incorrectly, and could potentially lead to permanent damage with resulting negative consequences for gamete health (Petrillo et al , 2011; Summers et al , 2011). Two major pathways can repair DNA DSB's: Non-Homologous End Joining (NHEJ) (Chiruvella et al , 2012) and Homologous Recombination (HR) (Scully et al , 1997). Key signaling molecules involved in NHEJ repair include the X-ray repair complementing defective repair in Chinese hamster cells 6 and 5 (XRCC6 and XRCC5) heterodimer which recognizes and binds to the DSB, recruiting protein kinase DNA-activated, catalytic polypeptide (PRKDC) to the DSB ends (Calsou et al , 2003; Dobbs et al , 2010; Chiruvella et al , 2012).…”
Section: Introductionmentioning
confidence: 99%
“…Two major pathways can repair DNA DSB's: Non-Homologous End Joining (NHEJ) (Chiruvella et al , 2012) and Homologous Recombination (HR) (Scully et al , 1997). Key signaling molecules involved in NHEJ repair include the X-ray repair complementing defective repair in Chinese hamster cells 6 and 5 (XRCC6 and XRCC5) heterodimer which recognizes and binds to the DSB, recruiting protein kinase DNA-activated, catalytic polypeptide (PRKDC) to the DSB ends (Calsou et al , 2003; Dobbs et al , 2010; Chiruvella et al , 2012). During HR, breast cancer type 1 (BRCA1) can be phosphorylated by ATM and co-localizes with RAD51 recombinase (RAD51) at the site of DNA damage to induce DSB repair (Scully et al , 1997).…”
Section: Introductionmentioning
confidence: 99%